Kirkland chair Jon Ballis said the firm remains focused on capturing market share but also keeping clients satisfied and ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Over the course of my career, I have filed around 160 appeals and have guidelines that I follow to optimize my chances of ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

In May 2020, the Patent Trial and Appeal Board (“PTAB”) panel in Apple Inc. v. Fintiv, Inc. (IPR2020-00019) denied institution of Apple’s petition ...

Eylea has been a significant revenue driver for Regeneron, and any potential impact on its sales due to competition from biosimilars is closely watched by investors. The court’s ruling thus represents ...

Fish & Richardson bumped gross revenue up to nearly $520 million in 2024. President and CEO John Adkisson attributed the gain ...

On Tuesday, the Trump administration nominated John Squires, a partner in the New York office of Dilworth Paxon LLP, as director of the United ...

Eric J. Fues and Kyle W. Howarth of Finnegan discuss decisions exploring the multi-pronged analysis in patent law for ...

On the 13th, the 24th division of the Patent Court (Director General WOOSUNG) partially accepted the claims of LS Cable & ...